News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,542 Results
Type
Article (44234)
Company Profile (315)
Press Release (703973)
Multimedia
Podcasts (127)
Webinars (22)
Section
Business (211196)
Career Advice (2117)
Deals (36810)
Drug Delivery (139)
Drug Development (83557)
Employer Resources (176)
FDA (16899)
Job Trends (15536)
News (357817)
Policy (34158)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2640)
Accelerated approval (43)
Adcomms (27)
Allergies (171)
Alliances (51615)
ALS (202)
Alzheimer's disease (1780)
Antibody-drug conjugate (ADC) (431)
Approvals (17244)
Artificial intelligence (646)
Autoimmune disease (249)
Automation (53)
Bankruptcy (373)
Best Places to Work (11775)
BIOSECURE Act (21)
Biosimilars (218)
Biotechnology (189)
Bladder cancer (182)
Brain cancer (72)
Breast cancer (714)
Cancer (5635)
Cardiovascular disease (471)
Career advice (1801)
Career pathing (42)
CAR-T (314)
CDC (57)
Celiac Disease (2)
Cell therapy (836)
Cervical cancer (44)
Clinical research (72077)
Collaboration (2043)
Company closure (4)
Compensation (1326)
Complete response letters (83)
COVID-19 (2807)
CRISPR (106)
C-suite (1070)
Cystic fibrosis (154)
Data (7439)
Decentralized trials (3)
Denatured (38)
Depression (159)
Dermatology (70)
Diabetes (564)
Diagnostics (6964)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (314)
Drug pricing (214)
Drug shortages (34)
Duchenne muscular dystrophy (272)
Earnings (92974)
Editorial (66)
Employer branding (21)
Employer resources (155)
Events (121859)
Executive appointments (1079)
FDA (20485)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1677)
Gene editing (223)
Generative AI (57)
Gene therapy (688)
GLP-1 (1079)
Government (4859)
Grass and pollen (7)
Guidances (403)
Healthcare (19158)
HIV (77)
Huntington's disease (53)
IgA nephropathy (95)
Immunology and inflammation (291)
Immuno-oncology (87)
Indications (167)
Infectious disease (3138)
Inflammatory bowel disease (212)
Inflation Reduction Act (14)
Influenza (134)
Intellectual property (283)
Interviews (329)
IPO (16936)
IRA (57)
Job creations (4078)
Job search strategy (1503)
JPM (65)
Kidney cancer (18)
Labor market (94)
Layoffs (586)
Leadership (38)
Legal (8428)
Liver cancer (99)
Longevity (31)
Lung cancer (752)
Lymphoma (419)
Machine learning (57)
Management (60)
Manufacturing (995)
MASH (184)
Medical device (13979)
Medtech (14062)
Mergers & acquisitions (21071)
Metabolic disorders (1473)
mRNA (201)
Multiple sclerosis (180)
NASH (18)
Neurodegenerative disease (397)
Neuropsychiatric disorders (104)
Neuroscience (3248)
Neurotech (1)
NextGen: Class of 2026 (6658)
Non-profit (4574)
Now hiring (74)
Obesity (698)
Opinion (309)
Ovarian cancer (204)
Pain (258)
Pancreatic cancer (274)
Parkinson's disease (349)
Partnered (34)
Patents (573)
Patient recruitment (627)
Peanut (64)
People (61446)
Pharmaceutical (86)
Pharmacy benefit managers (34)
Phase 1 (22371)
Phase 2 (31705)
Phase 3 (23733)
Pipeline (7670)
Policy (324)
Postmarket research (2660)
Preclinical (9542)
Press Release (68)
Prostate cancer (285)
Psychedelics (54)
Radiopharmaceuticals (321)
Rare diseases (1052)
Real estate (6316)
Recruiting (72)
Regulatory (26053)
Reports (55)
Research institute (2466)
Resumes & cover letters (362)
Rett syndrome (34)
RNA editing (22)
RSV (88)
Schizophrenia (177)
Series A (279)
Series B (209)
Service/supplier (11)
Sickle cell disease (111)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (47)
Startups (3783)
State (2)
Stomach cancer (19)
Supply chain (128)
Tariffs (99)
The Weekly (87)
Vaccines (1102)
Venture capital (103)
Weight loss (458)
Women's health (117)
Worklife (20)
Date
Today (145)
Last 7 days (733)
Last 30 days (2773)
Last 365 days (30888)
2026 (9758)
2025 (30696)
2024 (35773)
2023 (40645)
2022 (51823)
2021 (56347)
2020 (54808)
2019 (47440)
2018 (35796)
2017 (33153)
2016 (32696)
2015 (38658)
2014 (32537)
2013 (27648)
2012 (29743)
2011 (30502)
2010 (28521)
Location
Africa (806)
Alabama (91)
Alaska (7)
Arizona (345)
Arkansas (16)
Asia (42518)
Australia (6823)
California (12674)
Canada (3644)
China (1317)
Colorado (543)
Connecticut (548)
Delaware (384)
Europe (91481)
Florida (1899)
Georgia (404)
Hawaii (3)
Idaho (64)
Illinois (1021)
India (89)
Indiana (587)
Iowa (23)
Japan (523)
Kansas (130)
Kentucky (47)
Louisiana (41)
Maine (75)
Maryland (1526)
Massachusetts (9083)
Michigan (353)
Minnesota (693)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (84)
New Jersey (3368)
New Mexico (29)
New York (3340)
North Carolina (1624)
North Dakota (8)
Northern California (6294)
Ohio (376)
Oklahoma (24)
Oregon (46)
Pennsylvania (2567)
Puerto Rico (28)
Rhode Island (50)
South America (1184)
South Carolina (84)
South Dakota (2)
Southern California (4986)
Tennessee (203)
Texas (2003)
United States (44962)
Utah (379)
Vermont (1)
Virginia (314)
Washington D.C. (80)
Washington State (1020)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
748,542 Results for "horizon pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
April 7, 2026
·
6 min read
Press Releases
Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit
March 9, 2026
·
3 min read
Press Releases
Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows
April 21, 2026
·
4 min read
Press Releases
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation
February 22, 2026
·
11 min read
Press Releases
Crystalys Therapeutics Appoints Tim Walbert, Former Horizon Therapeutics CEO, as Independent Board Director
February 11, 2026
·
3 min read
Press Releases
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
March 31, 2026
·
1 min read
Press Releases
Theolytics Awarded €8 million in Horizon Europe 2025 Grant Funding to Advance Phase 2 Study of THEO-260 in Ovarian Cancer
March 4, 2026
·
5 min read
Press Releases
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
March 25, 2026
·
8 min read
Press Releases
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
February 19, 2026
·
7 min read
Press Releases
Egle Therapeutics and Consortium Partners Awarded €8 Million Grant from Horizon Europe to Advance Clinical Development of EGL-001 in Neoadjuvant Head and Neck Cancer
March 2, 2026
·
4 min read
1 of 74,855
Next
